PHAXIAM Therapeutics S.A.

DB:2E40 Stock Report

Market Cap: €15.9m

PHAXIAM Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2E40?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders72,1160.72%
Private Companies225,2102.25%
Institutions3,830,47838.3%
General Public5,885,66558.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.8%.

Top Shareholders

Top 25 shareholders own 41.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25%
EPIC Bpifrance, Asset Management Arm
2,500,000€4.0m0%5.27%
4.75%
Go Capital SAS
475,606€756.2k1,500%41.26%
4.71%
Tikehau Investment Management SAS
471,777€750.1k0%0.43%
2.05%
Akkadian Partners S.A.
205,695€327.1k0%no data
0.96%
Aviva Investors Global Services Ltd.
95,956€152.6k0%no data
0.54%
SAS Helea Financière
54,375€86.5k0%no data
0.54%
Auriga Partners
54,181€86.1k0%2.37%
0.43%
Rossini Investments S.à R.L.
43,103€68.5k0%no data
0.31%
Valentine Gouedard Comte
31,193€49.6k0%no data
0.26%
Solys
26,189€41.6k0%no data
0.24%
Myropola
24,042€38.2k0%no data
0.17%
Bpifrance Participations SA
17,418€27.7k0%no data
0.16%
MP Deloche & Associates SARL
16,100€25.6k0%no data
0.15%
Paminove
15,376€24.4k0%no data
0.15%
Sc Roc De Lou
15,108€24.0k0%no data
0.14%
Mathieu Bigois
13,700€21.8k0%no data
0.12%
Sofidu
11,854€18.8k0%no data
0.12%
Financiere Saint Romain
11,854€18.8k0%no data
0.09%
Jacques Tcheng
9,016€14.3k0%no data
0.076%
Guy Rigaud
7,576€12.0k0%no data
0.06%
Gestys SA
6,000€9.5k0%0.38%
0.055%
Thibaut Fayet
5,486€8.7k0%no data
0.034%
Friedland Gestion
3,375€5.4k0%0.11%
0.026%
Bernard Linage
2,626€4.2k0%no data
0.01%
Philippe Archinard
1,030€1.6k0%no data